HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Goette Selected Research

Olmesartan Medoxomil (Votum)

2/2012Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial.
1/2007Angiotensin II antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial: rationale and study design.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Goette Research Topics

Disease

90Atrial Fibrillation
01/2022 - 07/2002
32Stroke (Strokes)
06/2021 - 11/2002
22Hemorrhage
06/2021 - 01/2009
17Heart Failure
01/2022 - 03/2006
15Myocardial Infarction
06/2021 - 11/2014
10Thrombosis (Thrombus)
06/2021 - 11/2002
8Fibrosis (Cirrhosis)
10/2013 - 10/2002
7Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2007
6Hypertension (High Blood Pressure)
11/2020 - 04/2006
6Cardiac Arrhythmias (Arrythmia)
08/2020 - 02/2008
6Embolism (Embolus)
01/2018 - 10/2008
6Tachycardia (Tachyarrhythmias)
04/2015 - 06/2006
5Acute Coronary Syndrome
01/2021 - 12/2009
5Thromboembolism
12/2018 - 01/2009
5Atrial Remodeling
01/2014 - 04/2007
4Heart Diseases (Heart Disease)
03/2014 - 04/2006
4Coronary Disease (Coronary Heart Disease)
06/2012 - 12/2009
4Angina Pectoris
01/2012 - 01/2007
3Hypertrophy
06/2012 - 06/2006
2Body Weight (Weight, Body)
06/2020 - 05/2015
2Infarction (Infarctions)
01/2018 - 10/2015
2Diabetes Mellitus
01/2018 - 05/2011
2Kidney Diseases (Kidney Disease)
01/2018 - 01/2017
2Ischemia
01/2018 - 06/2012
2Left Ventricular Dysfunction
09/2013 - 10/2011
2Ventricular Tachycardia
02/2012 - 10/2011
2ST Elevation Myocardial Infarction
01/2012 - 06/2009
2Cardiomyopathies (Cardiomyopathy)
10/2011 - 01/2004
2Mitochondrial Diseases (Mitochondrial Disease)
05/2008 - 06/2006
1Acidosis
09/2022
1MELAS Syndrome (Syndrome, MELAS)
09/2022
1Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome)
09/2022
1Infections
01/2021
1Obesity
12/2020
1Ischemic Stroke
11/2020
1Transient Ischemic Attack
11/2020
1COVID-19
07/2020

Drug/Important Bio-Agent (IBA)

20edoxabanIBA
06/2021 - 11/2014
19Warfarin (Coumadin)FDA LinkGeneric
06/2021 - 04/2004
18AnticoagulantsIBA
01/2021 - 01/2012
17Vitamin KFDA Link
01/2021 - 01/2009
14Angiotensin IIIBA
05/2017 - 06/2003
11Enoxaparin (Lovenox)FDA LinkGeneric
11/2020 - 05/2015
10N(4)-oleylcytosine arabinosideIBA
01/2021 - 11/2014
10Pharmaceutical PreparationsIBA
11/2020 - 04/2004
7Anti-Arrhythmia AgentsIBA
01/2021 - 10/2008
6DronedaroneFDA Link
01/2022 - 06/2015
6CalciumIBA
04/2015 - 07/2002
5Factor Xa InhibitorsIBA
11/2020 - 05/2011
5DabigatranFDA Link
11/2017 - 11/2009
4CreatinineIBA
11/2020 - 05/2017
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2020 - 08/2017
4Proteins (Proteins, Gene)FDA Link
01/2018 - 06/2006
4RivaroxabanIBA
11/2017 - 05/2013
4apixabanIBA
11/2017 - 05/2013
4CalpainIBA
04/2014 - 10/2009
32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
11/2020 - 01/2020
3NicotineFDA Link
06/2012 - 09/2007
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2020 - 02/2012
2Factor X (Stuart Factor)IBA
02/2020 - 12/2015
2ORALIT (ORS)IBA
01/2020 - 01/2018
2Ion Channels (Ion Channel)IBA
08/2019 - 04/2007
2ProteomeIBA
01/2018 - 01/2004
2Flecainide (Tambocor)FDA LinkGeneric
06/2017 - 02/2011
2AntithrombinsIBA
12/2015 - 11/2014
2Factor Xa (Coagulation Factor Xa)IBA
11/2014 - 10/2013
2Peptide Hydrolases (Proteases)FDA Link
03/2014 - 09/2013
2ThrombinFDA Link
10/2013 - 05/2011
2SmokeIBA
06/2012 - 08/2009
2Angiotensin Receptors (Angiotensin II Receptor)IBA
02/2012 - 02/2008
2Olmesartan Medoxomil (Votum)FDA Link
02/2012 - 01/2007
2N,N-dimethylarginine (asymmetric dimethylarginine)IBA
01/2012 - 10/2011
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2012 - 05/2010
2TroponinIBA
01/2012 - 06/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2011 - 11/2002
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2010 - 01/2007
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2008 - 04/2007
2IrbesartanFDA LinkGeneric
02/2008 - 01/2008
2Cell Adhesion MoleculesIBA
02/2008 - 01/2008
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
02/2008 - 01/2008
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2008 - 04/2007
2von Willebrand FactorIBA
01/2008 - 04/2004
2C-Reactive ProteinIBA
01/2008 - 04/2007
1Mitochondrial DNA (mtDNA)IBA
09/2022
1Lactic Acid (Lactate)FDA LinkGeneric
09/2022
1Sotalol (Sotalol Hydrochloride)FDA LinkGeneric
01/2022
1dofetilide (Tikosyn)FDA Link
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
11/2020
1APTIBA
11/2020
1CytokinesIBA
07/2020

Therapy/Procedure

43Therapeutics
01/2022 - 08/2006
19Electric Countershock (Cardioversion)
11/2020 - 09/2006
8Catheter Ablation
09/2022 - 12/2009
8Percutaneous Coronary Intervention
01/2021 - 01/2018
6Stents
06/2021 - 01/2018
3Secondary Prevention
01/2022 - 02/2012
3Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
08/2014 - 10/2011
2Radiofrequency Ablation
01/2020 - 02/2012
2Defibrillators (Defibrillator)
03/2017 - 08/2014